Sonnet BioTherapeutics Holdings, Inc. SONN
1.26 0.00 0.00%
At close · Dec 2
- YTD
- -13.70%
- 1 year
- -51.72%
- Open
- 3.16
- Prev close
- 1.26
- Mkt cap
- 4.33M
- Vol
- 10.43M
- Avg vol
- 1.33M
- EPS
- -11.35
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.26
- High
- 3.23
- Forward P/E
- -0.10
- Beta
- 1.04
- Short ratio
- 0.03
- Inst. own
- 0.20%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 12, 2025
- 50-d avg
- 3.46
- 200-d avg
- 8.63
- 1y target
- 160.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for SONN has not been loaded yet. Try again in a moment.
Altman Z-Score
-10.45 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -1.2×
P/S 18.7×
P/B 1.7×
P/FCF -1.5×
EV/EBITDA 153×
EV/Sales 13.6×
FCF Yield -68.6%
Gross Margin 0.0%
Operating Margin -1584.4%
Net Margin -1611.3%
ROE -149.4%
ROIC -144.2%
ROA -108.3%
Revenue 5268.8%
Operating Income -33.7%
EPS (diluted) 65.2%
Free Cash Flow -49.0%
Current Ratio 3.5×
Quick Ratio 3.5×
Debt / Equity 0.0×
Net Debt / EBITDA -56.8×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-09-30